Introduction
A Phase III randomized clinical trial is concerned with assessing the relative efficacy of various treatment interventions in human subjects. The hypotheses to be tested in such a trial may be one-sided (e.g., testing whether a new treatment is more effective than placebo) or two-sided (e.g., testing which of two treatments is better with some allowance for a decision of equality). It is widely recognized that the use of human subjects demands interim analyses of the data. It would be a violation of medical ethics to continue patients on an inferior treatment regimen when sufficient evidence is available to decide which treatment is better. However, truly sequential designs, in which an analysis is performed following each observation, are most often impractical. This paper is concerned with the use of one alternative approach that has received widespread attention: the group sequential design (Pocock, 1977 (Pocock, , 1982 ; O'Brien and Fleming, 1979; DeMets and Ware, 1980 Ware, , 1982 . We restrict our attention to the case of inference about the mean of a normally distributed response with known variance. As delineated in Whitehead (1983) , this case is applicable to the exact or asymptotic distribution of a wide variety of test statistics commonly encountered in clinical trials. Generalization of the results of this paper to other exact distributions is also straightforward.
We consider a group sequential design in which we have potential independent observations Yj we continue collecting data to observe S,,,,. We require that '7-0, the empty set, to guarantee that the study terminates by the mth analysis. We define statistics M mink: Sk t Fk. and S SAl. The event {M = kJ corresponds to stopping a study after the kth analysis and deciding in favor of or against the null hypothesis according to S E 520) or S E <2'), respectively. The operating characteristics of this test are governed by the particular choice for the continuation and stopping sets. These operating characteristics can be determined through the method of recursive numerical integration as described in Armitage, McPherson, and Rowe (1969) .
In this paper we are concerned with the choice of continuation and stopping sets that will treat the null and alternative hypotheses symmetrically with respect to early stopping. We shall assume that the variance a2 is known and that the numbers of subjects accrued between analyses, ni, i = 1, . . ., m, are free to be fixed by design. We further assume that the alternative specified in the hypothesis test represents the minimal improvement effected by a new treatment that will be of clinical importance. Formal stopping rules for clinical trials are usually based on some single measurement of treatment outcome. In reality, there are multiple secondary factors that influence the clinical value of a new treatment. Thus, the specific value chosen for the alternative hypothesis is assumed to be based on the therapeutic index, which will contrast improvements in treatment efficacy against differences between the treatments in toxicity, side effects, cost, administration, and other nonoutcome-related characteristics of the treatment.
In Section 2, we first consider the setting of one-sided hypothesis testing for a fixed maximum number of analyses, m, and with equal group sizes (i.e., ni = n). In Section 3 we discuss the efficiency of these one-sided symmetric designs in a one-parameter family of group sequential tests. These results are then extended to two-sided tests in Section 4. In Section 5 we discuss the problem of testing when the number of analyses and the sizes of groups accrued between analyses are random. Our results are summarized in Section 6.
One-Sided Hypothesis Tests
Suppose we wish to test the hypotheses Ho: At -Ao versus HI: At 3 AI1, where AI1 > Lo. We assume that the maximum number of analyses, m, is fixed in advance, and that the sizes of the groups accrued between analyses are all equal to n, which is free to be fixed by design. Designing our test will be made easier by first applying a location-scale transformation on the response variables in order to standardize the problem. Under the transformations and J,<(') to obtain a test of H*: ( < 0 versus H*: ( ,> 63 that has the desired operating characteristics. We can then determine the continuation and stopping sets for the original test of Heo versus H. by applying the inverse transformation to A,;*, 5c(0), and *<'). Since we have assumed that the value of n is to be determined in the process of designing the clinical trial, in this transformed test we are free to let the value of 6, be set by the design. The value of 6, that is dictated by a particular design will determine the value of n according to the formula n = Il (2) Consider first the case of m = 1, the fixed sample case. We have that S* = X*, and the uniformly most powerful level ae test would prescribe that the critical region ,*"1) would consist of the interval [z' o), where z(-) denotes the upper ar quantile of the standard normal distribution. The power to detect the alternative is given by d(b) = 1 -b(z () -), where (D(x) is the standard normal distribution function. In experimental design, we usually fix the sample size n to achieve some desired power under the alternative. However, as described above, in this transformed setting we may equivalently find an alternative that has the prescribed power. If we choose 6, = 2z (a) so that 1(( I) = 1 -o, our test will treat the hypotheses symmetrically in the sense that both the Type I and Type II statistical errors have probability equal to ax. Interchanging the role of null and alternative values for the mean will not alter the boundary of the critical region. Furthermore, the usual 100(1 -2a)% two-sided confidence interval constructed about the observed value will perfectly discriminate between the null and alternative hypotheses. That is, such a confidence interval has zero probability of containing both the null and alternative hypothesized means.
The ethical constraints of clinical trials might suggest such a symmetric treatment of the hypotheses. The goal is to provide all patients with the best treatment as soon as there is sufficient evidence to make such a decision, regardless of whether the better treatment is the newer or existing treatment. However, in many of the group sequential designs that have been proposed, this symmetry is lacking.
The earliest proposals for group sequential designs were primarily two-sided tests. Following the repeated significance testing of Armitage et al. (1969) , Pocock (1977) considered tests in which the usual fixed sample statistic, I S*/IIk 1, would be compared to a critical value c(a) at each analysis, instead of z (a) as would be used in a fixed sample design. If the test statistic were larger than the critical value at some analysis, the study would terminate with rejection of the null hypothesis. Otherwise, the study would continue until the mth analysis, at which time if the test statistic were less than the critical value, the study would terminate with failure to reject the null. The critical values c(7) resulting in level ae sequential tests were tabulated for various choices of m and af. O'Brien and Fleming (1979) proposed a design that would allow testing more conservatively at the earlier analyses and near the nominal level at the final analysis by comparing the statistic I S* I to an appropriate critical value cs' at each analysis. Both of these designs have continuation sets that are symmetric about the origin and are determined only by the null distribution.
A naive approach to determining group sequential boundaries for a one-sided hypothesis test is to use the two-sided boundaries above and to interpret early termination of a study with large negative values for S* as failure to reject the null. By way of example, such an adaptation of the O'Brien-Fleming design would define continuation and stopping sets by DeMets and Ware (1980) noted that the use of these designs for testing a one-sided hypothesis would terminate a study much earlier for evidence inconsistent with the null (when the alternative is true) than for evidence inconsistent with the alternative (when the null is true). They proposed a test modelled after the sequential probability ratio test of Wald (1947) 
The constraint that WF = 0 demands that a,,, = b,,, and we obtain = 2b, 
will have size ae under the null hypothesis. Lower values for the parameter p correspond to increasingly conservative testing at the earlier analyses. A design based on p = 0 corresponds to the O'Brien-Fleming symmetric test, while p = .5 is the Pocock symmetric test. We note that a design based on p = 1 degenerates to a fixed sample design. It is through the selection of the parameter p that a researcher can allow for determination of secondary questions related to a treatment. Higher choices of p result in a higher probability of terminating a study at an earlier analysis. In such a case, there might be little opportunity to assess the long-term efficacy or side effects of the treatment. Choosing a lower value for p will allow protection against marked differences between treatments while ensuring that ample information is available for measuring the secondary factors when the treatments are more similar with respect to the primary outcome. Selection of this parameter is most often quite subjective.
The major advantage of restricting our attention to such a family of boundary relationships is that each one-sided symmetric test design is dependent on a single critical value. Thus, we can easily tabulate these designs for various values of m, (x, and p. (2) and (4) From Table 1 , we find the critical value C(.05) = 3.404. Using equations (5) and (6), we find 61 = 1.702, and using equation (2) we have n = 6.76 for o2 = .21 (under HO), n = 7.72 for U2 = .24 (under H1), and n = 8.05 for U2 = .25 (if r = .5, the worst case in terms of variance). Thus, we might choose a group sample size of n = 8. Determining the boundaries according to equations (4)-(6), and inverting the transformation given by (1), we find the following continuation and stopping sets appropriate for Sk-I Xi (using a9 = .24). We express these continuation and stopping sets as continuous intervals in order to agree with the formulas, though the possible outcomes are of course discrete. In using such a test, we note that it will not have the exact nominal size of ae = .05. The reasons for this include the fact that the normal approximation was used (with n = 8 relatively small), that the outcome space is actually discrete, and that error was introduced in determination of the sample size due to the necessity of having integer group sizes. We find that the exact Type I and Type II statistical error probabilities are .0354 and .0501, respectively, using this test. This is relatively good agreement with the nominal value of .05 for each of these errors, given the discrete nature of the data. subsets, or desire for long-term follow-up may well affect the decision to terminate a study early. Proponents of the various "conservative early" designs, e.g., the O'Brien-Fleming (1979) design, contend that the choice of sequential design should also account for some of these other factors. A design that suggests early termination only in the presence of extreme evidence for one treatment over another will allow greatest flexibility to examine other response variables or long-term effects while maintaining adequate treatment of the ethical concerns in clinical trials.
However, in settings in which these other factors are expected to be of less concern, it seems reasonable to choose from a number of sequential designs according to the sample size required to perform the hypothesis test. Since the sample size is a random variable for a sequential test, we might choose to base our choice on any of several measures of efficiency such as the maximum sample size that might be required, the average sample number (ASN), or the variance of the sample size. For this paper, we shall follow the practice of previous researchers by considering the average sample number, which can be found by numerically integrating the sampling density. Unfortunately, we lack a uniformly most powerful test in the sequential setting, so comparisons must be based on some specific value for the unknown mean. Reasonable values to consider for such "optimization" would include 6 = 0 and 6 = 6 3/2. Note that the symmetry of our test design will provide identical results for 6 = 6( as for 6 = 0. The case 6 = 63/2 represents the worst case for any particular design. explored a one-parameter subset of these designs using the boundary relationships described in Section 2, and found that this subset achieved nearly full efficiency with respect to the grid search. Jennison (1987) considered the set of all one-sided symmetric designs satisfying (4) and (5), but shifted to be symmetric about zero, and found a four-parameter subset of these designs that achieved nearly full efficiency with respect to the larger search. We shall consider the one-parameter family of one-sided symmetric designs described in Section 2.
For given values of m, a, and 6, ASN was found to be a U-shaped function of p for 0 < p < 1. Starting with p = 0 and an interval of .1, we performed a grid search until an increase in ASN was found. The interval was then decreased and the search reversed until an increase in ASN was again found. This process was repeated until the minimum ASN was found for a grid interval of .001. Table 2 presents the "optimal" designs within the one-parameter family of one-sided symmetric designs for 6 = 0 (or 61) and 6 = 61/2. The ASN computed for each case is based on a value of (ul -uo)/a = 1. In order to convert the tabulated results to those appropriate for a specific case, multiply them by the quantity Table 2 as well.
To judge the loss of efficiency from restricting our search to this family of designs, we can compare our results to those of Jennison (1987) . Under the null (or alternative) hypothesis, we find that the one-parameter family of designs is approximately 99% efficient relative to the larger family of all symmetric designs. Under the intermediate hypothesis that 6 = 61/2, the relative efficiency is about 99.5%. From this we conclude that there is a minimal loss of efficiency when we restrict ourselves to the one-parameter family of designs.
Extension to Two-Sided Hypothesis Tests
The extension of symmetry to the case of two-sided hypothesis tests is not as straightforward. Suppose we are testing two existing treatments, say A and B. In the classical twosided hypothesis test, we want to decide whether A and B are equally effective, or whether one treatment is more efective than the other. In practice, however, we want to choose from among three possibilities: A < JU and HB: A > 1UB, with results midway between these hypotheses interpreted as rough equivalence between the treatments. For the purposes of test design, we define the null hypothesis of such a test as the midpoint of the "equivalence region." Thus, our approach is to design a test that has a specified size under the null hypothesis and a desired power under either of the alternatives. We shall choose these operating characteristics in such a way as to mimic the "symmetry" present in the fixed sample setting. where Al > 0 corresponds to the minimal amount of difference in treatment effect that is clinically important. To extend our group sequential notation to accommodate the three possible decisions, we partition the outcome space for the partial sum Sk into a continuation set Fk and stopping sets 5a(A), 5a(?), and 5a(B), corresponding to the decision to continue the sequential test or to stop and decide in favor of HA, HO, or HB, respectively.
For the one-sided test, we defined our test symmetric if the Type I and Type II statistical error probabilities were equal or, equivalently, if the appropriately sized confidence intervals would perfectly discriminate between the hypotheses. In deciding among the above three hypotheses, however, the characterization of the statistical errors is more complicated and the natural ordering of the hypotheses makes total symmetry among these errors undesirable. We therefore extend the concept of symmetry among the hypotheses only to the criterion of ability to discriminate perfectly the hypothesized values with appropriate confidence intervals.
For the case of a fixed sample design, the uniformly most powerful unbiased level a twosided test of HO has 
where dX?(,a is the critical value that results in a level a two-sided test of HO and the standardized alternative, y 1, is defined by As mentioned above, extending symmetric treatment of hypotheses to two-sided tests is only approximate, even in the fixed sample case. While the designs presented here are symmetric in their treatment of HA and HB, the null hypothesis HO is treated differently. This is reflected most notably in the larger values for the expected sample size (ASN) when A = 0 as compared with At = ay (or -yI). Table 4 decreasing with increasing m. From Table 4 it can be seen that the two-sided symmetric tests are nearly as efficient as the original designs under the alternative.
We should note that the marked improvement in efficiency of the symmetric tests proposed here under the null hypothesis compared with that of the original designs is not at all surprising. The original tests could be stopped with a decision in favor of the null only when the maximum sample size had been accrued. Thus, any tests that allow early stopping with acceptance of the null hypothesis will show improved efficiency with respect to those original designs when the null hypothesis is true. Whitehead and Stratton (1983) described an approximate test for this setting, the double triangular test, which showed similar improvements in efficiency. A further departure from the fixed sample case results from the sequential testing. In the sequential design, the probability of deciding HB when At = TyI is only approximately 1 -a/2. In general, the true power under the alternative is slightly higher than the designed power. The power under the alternative hypothesis for a level .05 two-sided symmetric test is typically .976 when p = 0 and .98 when p = .5. This slight increase in power can explain at least part of the slight reduction in efficiency noted above for the twosided symmetric designs compared to the original Pocock (1977) and O'Brien-Fleming (1979) designs under the alternative hypothesis. We note that power of the double triangular test under the alternatives is also different from the designed power, though it can be either slightly higher or lower, with approximately the same magnitude of error as the two-sided symmetric designs.
A key feature of the two-sided symmetric tests is the ability to terminate the study early with a decision in favor of the null hypothesis. Since that null hypothesis represents equivalence between the treatments, however, ethical considerations, at least on an individual level, are not as demanding. Thus, there are many conceivable situations in which such a design is not desirable. It the two treatments are approximately equal in efficacy, a researcher may want to continue a trial in order to assess secondary issues.
There are also many situations that call for early termination with a decision of equivalence. As a matter of efficiency (minimizing cost or time) or collective ethics (releasing patients to participate in future studies), it is often desirable to terminate a study as soon as one can be confident of the eventual outcome. Indeed, there is a large literature on early termination of negative studies using the futility index, which is defined as the conditional probability, usually under the alternative, of eventually rejecting the null hypothesis given the observations already collected (Ware, Muller, and Braunwald, 1985) . Obviously, the symmetric two-sided tests presented here could be interpreted in this fashion, though it is unlikely that a simple function of the futility index describes the stopping boundary. Instead, we have tried to define the stopping boundary under the null to have many of the same characteristics of the stopping boundary for the alternatives. In essence, the symmetric tests terminate under the null when the alternatives have been sufficiently ruled out, using the same criteria that are used to decide in favor of the alternative after the null has been ruled out. For convenience we parameterize these boundaries according to degree of conservatism at the earlier analyses, rather than an explicitly calculated probability.
An alternative method for constructing two-sided group sequential tests consists of superimposing two shifted one-sided symmetric tests in a manner similar to the superposition of triangular tests by Whitehead and Stratton (1983) . Such a method allows greater flexibility in design, since level a one-sided tests can be shifted and superimposed to provide an exact level a * two-sided test of Ho. However, the choice of a * = 2a results in a test only marginally different from those derived above. Furthermore, the added flexibility of these designs is balanced by the need to provide both a critical value for the one-sided tests and a shift parameter for the superposition. Results for these tests have not been presented here, though computer programs to calculate these parameters are available from the authors upon request.
Unequal Group Sizes and Varying Numbers of Analyses
The results of the preceding sections have been based on the premise that equal-sized groups would be accrued between successive analyses, i.e., testing occurs at intervals of equal information. In practice, this is often not feasible. When subject accrual rates vary over time, or when treatment outcome is measured after some delay, the rate of data accrual is often nonuniform in calendar time. Data monitoring committees, however, often meet on a regular basis and analyses are performed for discussion at these meetings. Such a setting can lead to four distinct departures from the assumptions of the earlier sections: (1) the group sizes are unequal, (2) the groups' relative sizes are unknown at the time of test design, (3) the number of analyses performed may be random, and (4) the sample size accrued by the final analysis may differ from that designed. In this section we discuss, in turn, the impact of these four departures on the use of the proposed symmetric tests. We shall limit this discussion to the case of one-sided tests, though it is not unreasonable to assume that the two-sided tests will behave in a similar fashion.
Generalization of these designs to the case of unequal group sizes is straightforward, though not easily tabulated. We now return to the fuller model of Section 1 where group sizes vary. We assume m is fixed in advance. If we perform the transformation (1) on this data for n = E I ni/m, we have that X* -N((n1/n )b 1, nI/n) under the alternative hypothesis.
We shall again define our test design for this transformed problem by basing the continuation and stopping sets on the partial sums Sk, for k = 1, . .., m.
Since we are concerned with experimental design, we cannot assume that the ni's are known prior to fixing the maximum sample size, which is chosen to yield a test having certain desired operating characteristics. Instead, we assume that the time of analyses will be fixed according to the proportion of the maximum sample size accrued. That is, we assume that the kth analysis will occur when a proportion, 7rk, of the maximum sample size, mn, has accrued. The proportions Irk (k = 1, ..., m) Clearly, this extension of the symmetric bounds resists tabulation. In practice, the proportion vector may be any of an infinite number of possibilities. Determination of the appropriate boundaries will need to be done on a case-by-case basis using a computer program to integrate the appropriate sequential density.
To explore the effect of testing with unequal group sizes, we consider a family of proportion vectors specified by lks irk = V-J It should be noted that when r < 1, the earlier group sizes are larger than later ones; conversely, when r > 1, earlier group sizes are smaller. This latter case corresponds most closely to the one that arises when testing is done at regular time intervals in a study with relatively uniform accrual of subjects, but an outcome measured by survival. In such a situation, the information accrued is most closely related to the number of deaths observed. Obviously, the delayed response will tend to mean less information at earlier analyses and relatively rapid accrual of information toward the end of the study. Note that r = 1 corresponds to testing with equal group sizes. For example, when m = 4, the proportion vectors are (.33, .57, .79, 1.0), (.25, .50, .75, 1.0), and (.12, .35, . 65, 1.0) when r = .8, 1.0, and 1.5, respectively.
In Table 5 we present critical values c(a) and average sample number (ASN) under the null hypothesis for selected values of a, p, and r when m = 4. From this it can be seen that the different values of r correspond to critical values that differ only slightly from the value for r = 1, the equal-information case. This then suggests that a reasonable approximation This then provides a strategy for dealing with the problem of testing according to calendar time when the relative sizes of the groups are not known in advance. A test can be designed using the critical value appropriate for equal-information testing. When the actual analyses are performed, (10) can be used to determine the continuation and stopping sets for an approximate level a test.
The results presented in Table 6 assume that only the planned number of analyses were performed, and furthermore that the mth analysis was performed when the planned maximal sample size had been accrued. In the setting of testing at equal intervals of calendar time, both of these assumptions may be violated. By the time of the mth planned analysis, the total sample size may be more or less than planned. Thus, a researcher may want to plan additional analyses when more data have accrued, or he may decide to complete the study with the existing sample.
Suppose a study is planned to have m analyses, but a decision is made to perform mn' analyses. For the moment we shall assume that the planned maximal sample size will be accrued by the m 'th analysis. In such a setting, the approximation represented by (10) can be applied to find stopping boundaries. We would expect the resulting test to be anticonservative if m' > m, and conservative otherwise. Performing more analyses than appropriate for the test design will inflate the Type I error rate. Similarly, we can predict the general effect of varying the maximal sample size accrued from that which was planned. If one wishes definitely to terminate a study with the "incorrect" final sample size at the mth analysis, the approximation in (10) cannot be used directly. If the final sample size were less than planned, the final continuation set would not be empty. If a larger sized sample were accrued, the stopping sets would not be disjoint. Selecting b,1, as defined in (10) as the final stopping boundary will tend to maintain the size of the test very close to the nominal level, but will cause the power under the alternative to vary. One solution to this problem that preserves the symmetry of the hypotheses is to use (10) to calculate aM7 and b,,, and then use (a,), + b,,7)/2 as the final stopping boundary. This approach will lead to anticonservative tests if a smaller sample is used, and conservative tests if the final sample is larger than appropriate for the value of c(7'lP.
As mentioned above, it may sometimes arise that several of these four problems will be present simultaneously. We would expect, as is the case, that these violated assumptions would have additive effects on the true size of the resulting test. In Table 7 we present the results of numerically computing the size of approximate tests in various settings. In all cases, we assume a test is designed using the equal-information-based critical value as given in Table 1 . For the cases of m = 4, a = .05, and p = 0 or .5, we examine the effects of varying the rate of data accrual (as measured by the parameter r), varying the number of analyses actually to be performed, mi', and varying the sample size accrued by the m 'th analysis, ,77 (measured as a proportion of the planned maximal sample size). From this table it can be seen that the symmetric test with O'Brien-Fleming-type boundary relationships (p = 0) is generally more robust to these departures than the test with the Pocock- Tables 6  and 7 are interpretable as the size of the test conditional on the test actually performed. Thus, if the random nature of the number and timing of analyses is considered a part of the design, the actual operating characteristics of a study will be a weighted average of measurements such as those presented in Table 7 .
It should be noted that more exact methods have been proposed for dealing with at least some of the listed departures from equal-information testing. Lan and DeMets (1983) and Fleming, Harrington, and O'Brien (1984) have proposed flexible rules for maintaining the exact size of a test when group sizes and numbers of analyses are random. Both of these methods define stopping boundaries based solely on the null hypothesis, and thus are not symmetric in their treatment of the hypotheses. As noted by Jennison (1987) , it is in general not possible to maintain symmetry between the Type I and Type II statistical error probabilities under random group sizes. We have thus focused on developing symmetric approximate tests, though the definition of approximately symmetric tests using a Lan and DeMets (1983) Type I error spending rate function or using the similar methods proposed by Fleming et al. (1984) might be equally appealing.
Such flexibility does not provide a solution to all the problems inherent in testing according to calendar time. The Lan and DeMets procedure is defined for a specific maximal sample size. Departures from the planned maximal sample size will necessitate either altering the predetermined Type I error spending rate function or allowing the size to vary from the nominal. Also, when planning a study, a researcher will need to estimate the number of analyses and the relative group sizes in order to determine the power function for the test. In general, the overall robustness of such a Lan and DeMets procedure will be commensurate to that of the symmetric tests. However, as with the case of using bn to define the final stopping boundary, the Lan and DeMets procedure will hold the size to the nominal level and allow the power under the alternative to vary. Planning and performing such a test requires the availability of computer programs capable of numerically integrating the density for the group sequential test statistic.
Thus, even if one of the more flexible procedures is to be used when the analyses are performed, the symmetric designs herein proposed can be used in designing the study. Since each design is dependent on a single, easily tabulated parameter, a researcher can determine sample size using only a hand calculator. Lan and DeMets type use functions that mimic the behavior of the symmetric test can be found and used in performing the test.
As a final comment, we note that none of the tests discussed in this section maintain their operating characteristics when the number and timing of analyses are determined by looking at the data. While some of these methods are reasonably robust to certain datadriven choices, a researcher must take care that any departures from the planned design not be so dependent on the observed results that the size of the test be unduly inflated.
Summary
In presenting group sequential designs that treat the hypotheses symmetrically, we have attempted to address those concerns relating to efficiency and medical ethics in Phase III clinical trials. The efficiency and robustness of the family of symmetric one-sided tests are comparable to those reported by Jennison (1987) , yet the test designs we have proposed are completely specified by a single parameter. Since the family of test designs covers a wide spectrum of tests in terms of the degree of conservatism at early analyses, there is much flexibility in accommodating the questions inherent in any clinical trial that are not directly related to the primary outcome. A researcher may choose test designs that have a greater probability of continuing to a larger sample size, thereby allowing secondary questions to be assessed. Upon choosing the maximal number of analyses, the level of significance, and the degree of conservatism desired at earlier analyses, a user can easily compute sample sizes and test boundaries for a sequential clinical trial using the critical values presented in this paper. Such tests are found to be easily adapted and relatively well behaved for departures from the equal-information setting.
In extending the symmetric design to the case of two-sided hypothesis tests, we have maintained the ease of specification of the group sequential design. These symmetric twosided group sequential tests, however, show marked improvement in expected sample size under the null hypothesis when compared with the originally proposed Pocock (1977) and O'Brien-Fleming (1979) two-sided tests, and are nearly as efficient as the original designs under the alternative hypothesis. In this respect, they are comparable to the approximate two-sided tests proposed by Whitehead and Stratton (1983) . Thus, the proposed test designs provide better overall treatment of the efficiency considerations when planning a two-sided clinical trial. It is reasonable to expect that the efficiency and robustness of these symmetric two-sided tests will be comparable to the one-sided tests.
